Milestone Max MYGA 7-Year review

Yes, with qualifications. For someone who has at least $25,000 to commit for a full seven years and wants a straightforward, single-rate locked annuity with a no-cost care waiver built in, Milestone Max is a reasonably competitive, low-drama choice. It's a weaker fit for someone chasing the highest possible locked rate on the market, someone with less than $25,000 to commit, or a resident of one of the states where it isn't sold.

The straightforward reason to buy Milestone Max is rate certainty: you know exactly what you'll earn for seven years, with no market exposure, no cap, and no participation rate to track. The secondary reason is the built-in terminal illness and nursing-home confinement waiver, which lets you access the full account value without a surrender charge or MVA if either event occurs — a feature many comparable MYGAs charge for or don't offer at all. In practical terms, this is a CD-like commitment for money you're confident you won't need for seven years, with a modest amount of downside protection built in if your health situation changes.

I think Milestone Max is best for someone in their 50s, 60s, or early 70s with at least $25,000 in non-immediate-need savings — often an IRA rollover or a maturing CD — who wants a locked seven-year rate and values the free terminal illness/nursing-home carve-out over squeezing out the last quarter-point of yield. It's a weaker fit for someone who might need meaningful access to principal before year seven, someone shopping specifically for the highest available locked rate (this isn't it), or a shopper in one of the seven states where the product isn't approved.

You're not buying growth potential or market participation. You're buying an insurance company's promise to pay a fixed, guaranteed rate of interest for seven years, full stop. There's no index, no cap, no spread, and no strategy menu to choose from — the entire pitch is the rate itself, plus the health-related access waiver. That simplicity is the point: what you see in the brochure is what you get, and the tradeoff for that certainty is giving up liquidity and any chance of outperforming the locked rate if markets or interest rates move higher after you buy.

Milestone Max credits a single declared fixed rate for the entire seven-year guarantee period, banded by premium size: 5.10% for premiums between $25,000 and $74,999, and 5.25% for $75,000 and above (rates as of the brochure date; confirm the current rate before applying, since MYGA rates reprice regularly). That's a real, if modest, edge over Sagicor's base Milestone MYGA 7-Year, which reaches its own top rate of 5.20% only at $100,000 and starts as low as 4.70% below $50,000 — Max's floor rate is 40 basis points higher than the base contract's floor, and Max's top rate arrives at a $25,000-lower premium threshold. Set against the broader A-rated MYGA market, though, where the strongest seven-year locked rates currently run close to 6.00%, Max's 5.10%-5.25% is solidly mid-pack rather than chart-topping.

The feature that actually distinguishes Max from its own base sibling is the penalty-free access waiver: if the owner is diagnosed with a terminal illness after the first contract year, or confined to a nursing home or care facility, up to 100% of the accumulation value can be withdrawn with no surrender charge and no MVA. It's structured as a built-in contract provision rather than a separately priced rider, so there's no explicit fee for it — Sagicor's base Milestone MYGA 7-Year doesn't offer this at all. For a buyer who's otherwise comfortable with the seven-year commitment, this is a real, no-cost hedge against the scenario that usually forces people to break a locked annuity early. What Max does NOT change, despite the name, is the surrender schedule or the MVA itself — both are identical to the base contract's national filing, so "Max" isn't buying more liquidity, just a better rate ceiling and the care waiver.

You're trading seven years of full liquidity for the locked rate. Free withdrawals are available starting in contract year two, capped at 10% of the prior anniversary's accumulation value each year, with a $500 minimum withdrawal. Anything beyond that free amount during the surrender period triggers both a surrender charge (starting at 9% in year one and stepping down to 3% by year seven) and a market value adjustment, which can cut either direction depending on where interest rates have moved since issue. Qualified accounts subject to RMDs can take the full required distribution penalty-free from year one on, even above the 10% cap starting in year two. A 30-day penalty-free window opens at the end of the seven-year term, but because this is a single-schedule contract, there's no repeating window after that — once the surrender period ends, the rate simply renews without another locked schedule attached.

There's no annual contract fee and no rider fee here — Max doesn't charge anything on top of the built-in rate and surrender structure, and the terminal illness/nursing-home waiver comes at no additional cost. The real cost of this contract isn't a line-item fee; it's opportunity cost. Locking $25,000 or more into a fixed rate for seven years means giving up the ability to move that money if a better rate, or a need for liquidity, shows up in year three or four. The MVA adds a second layer of uncertainty on top of the surrender charge for any withdrawal beyond the free amount, since it can make an early exit more expensive than the surrender schedule alone would suggest.

Legal Entity: Sagicor Life Insurance Company

Parent: Sagicor Financial Company, Ltd.

A.M. Best Rating: A-